Treatment of Advanced HCC with Durvalumab and Tremelimumab: Patient Case Study

AI Models as a Valuable Genetic Counseling Resource in Gynecologic Oncology

Artificial intelligence (AI) models are proving to be an indispensable tool in the field of gynecologic oncology, offering additional support for genetic counseling. These AI models are transforming the way healthcare providers approach patient care, especially in the realm of genetic testing and counseling.

Disparities in Care Outcomes between Black and White Patients with Endometrioid Endometrial Carcinoma

A concerning trend persists in gynecologic oncology regarding disparities in care outcomes between Black and White patients with endometrioid endometrial carcinoma. Despite advances in treatment options, there remains a significant gap in the quality of care received by patients of different racial backgrounds. Addressing these disparities is crucial in ensuring equitable healthcare for all individuals.

Laparoscopic vs Open Surgery in Advanced Ovarian Cancer: Insights from Dr. Hayek

Dr. Hayek shares insights on the debate between laparoscopic and open surgery in the treatment of advanced ovarian cancer. With advancements in surgical techniques, understanding the benefits and risks of each approach is essential in optimizing patient outcomes and quality of life post-surgery.

PROs with Pembrolizumab Plus Chemoradiotherapy in Cervical Cancer: Expert Analysis by Dr. Randall

Dr. Randall provides expert analysis on patient-reported outcomes (PROs) with pembrolizumab plus chemoradiotherapy in the management of cervical cancer. By highlighting the benefits and challenges associated with this treatment approach, healthcare providers can make more informed decisions to personalize care for patients with cervical cancer.